May 26, 2016 5:17 PM ET

Biotechnology

Company Overview of miRagen Therapeutics, Inc.

Key Executives for miRagen Therapeutics, Inc.

NameBoard RelationshipsTitleAge
William S. Marshall Ph.D.32 RelationshipsCo-Founder, Chief Executive Officer, President and Director--
Bruce L. Booth D.Phil., Ph.D.111 RelationshipsCo-Founder and Chairman of The Board 41
Michael R. Bristow M.D., Ph.D.17 RelationshipsCo-Founder and Member of the Scientific Advisory Board70
Marvin H. Caruthers Ph.D.48 RelationshipsCo-Founder and Director75
Eric N. Olson Ph.D.62 RelationshipsCo-Founder and Member of Scientific Advisory Board--
View More Key Executives

miRagen Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bruce L. Booth D.Phil., Ph.D. 111 RelationshipsmiRagen Therapeutics, Inc.41
William S. Marshall Ph.D. 32 RelationshipsmiRagen Therapeutics, Inc.--
Eric N. Olson Ph.D. 62 RelationshipsmiRagen Therapeutics, Inc.--
Michael R. Bristow M.D., Ph.D. 17 RelationshipsARCA biopharma, Inc.70
Marvin H. Caruthers Ph.D. 48 RelationshipsmiRagen Therapeutics, Inc.75
View All Board Members

miRagen Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
380.0K
Bonus
251.2K
Total Short Term Compensation
469.9K
Total Value of Options
33.7M
Compensation as of Fiscal Year
miRagen Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sarah Kalil Resigns as Chief Operating Officer of T2 Biosystems, Inc
May 25, 2016 6:49 PM ET
Pharming Group NV Announces Management Changes
May 25, 2016 5:00 PM ET
Transgene Announces Board Changes
May 25, 2016 4:30 PM ET
Aquinox Pharmaceuticals Inc. Announces Executive Appointments
May 25, 2016 1:15 PM ET
Alder BioPharmaceuticals, Inc. Announces Management Appointments
May 25, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact miRagen Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.